dabigatran has been researched along with Bilateral Headache in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, Y; Tang, Z; Xu, S; Zhu, W | 1 |
Rathgen, K; Roth, W; Shakeri-Nejad, K; Stähle, H; Stangier, J | 1 |
1 trial(s) available for dabigatran and Bilateral Headache
Article | Year |
---|---|
Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Area Under Curve; Benzimidazoles; Biological Availability; Blood Proteins; Dabigatran; Erythema; Female; Glucuronides; Half-Life; Headache; Hepatic Insufficiency; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Prodrugs; Prothrombin Time; Pyridines; Severity of Illness Index; Sex Factors; Thrombin | 2008 |
1 other study(ies) available for dabigatran and Bilateral Headache
Article | Year |
---|---|
Clinical Reasoning: A teenager with persistent headache.
Topics: Adolescent; Anticoagulants; Blood Proteins; Brain; Dabigatran; Diuretics, Osmotic; Frameshift Mutation; Headache; Heparin, Low-Molecular-Weight; Humans; Intracranial Hypertension; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Phlebography; Protein S; Protein S Deficiency; Sinus Thrombosis, Intracranial | 2019 |